AR and ovarian cancer: Accumulating evidence indicates that high-level expression of AR is associated with progression in various types of cancers, including colorectal cancer [56, 57], breast cancer [58, 59], ovarian cancer [60, 61], pancreatic cancer [62, 63], lung cancer [64, 65], liver cancer [66, 67], and oral cancer [68].